Oncogenic Transformation by Inhibitor-Sensitive and -Resistant EGFR Mutants

BACKGROUND: Somatic mutations in the kinase domain of the epidermal growth factor receptor tyrosine kinase gene EGFR are common in lung adenocarcinoma. The presence of mutations correlates with tumor sensitivity to the EGFR inhibitors erlotinib and gefitinib, but the transforming potential of specif...

Descripción completa

Detalles Bibliográficos
Autores principales: Greulich, Heidi, Chen, Tzu-Hsiu, Feng, Whei, Jänne, Pasi A, Alvarez, James V, Zappaterra, Mauro, Bulmer, Sara E, Frank, David A, Hahn, William C, Sellers, William R, Meyerson, Matthew
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2005
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1240052/
https://www.ncbi.nlm.nih.gov/pubmed/16187797
http://dx.doi.org/10.1371/journal.pmed.0020313

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1240052/
https://www.ncbi.nlm.nih.gov/pubmed/16187797
http://dx.doi.org/10.1371/journal.pmed.0020313

Ejemplares similares